Eun-Ji Lee , Hoon-Min Lee , Hyun-Seung Kim , So Hui Ryu , Mi-Jung Kang , Jungmok You , Yeon-Gu Kim
{"title":"Investigating the effect of linker peptides on the fragmentation of Fc-fusion proteins in transient gene expression of mammalian cells","authors":"Eun-Ji Lee , Hoon-Min Lee , Hyun-Seung Kim , So Hui Ryu , Mi-Jung Kang , Jungmok You , Yeon-Gu Kim","doi":"10.1016/j.procbio.2024.11.010","DOIUrl":null,"url":null,"abstract":"<div><div>Protein fragmentation is a critical quality attribute for Fc-fusion protein production in mammalian cells. In the production of viral non-structural proteins as the form of Fc-fusion protein, fragmentation of Fc-fusion proteins occurred in two transient gene expression (TGE) systems with human embryonic kidney (HEK) 293 and Chinese hamster ovary (CHO) cells. The introduction of a flexible empirical linker reduced fragmentation in HEK293 cells, but not in CHO cells. Additionally, two rigid empirical linkers failed to restore impaired Fc-fusion proteins in CHO cells. <em>In vitro</em> incubation assay using conditioned culture medium and cultures supplemented with protease inhibitor cocktail suggest that fragmentation of Fc-fusion proteins in CHO cells may be due to various host cell proteins released into the culture medium. These findings suggest that the introduction of linker peptides can improve the fragmentation of Fc-fusion proteins in mammalian cells, but exhibit different fragment patterns depending on the cell type.</div></div>","PeriodicalId":20811,"journal":{"name":"Process Biochemistry","volume":"147 ","pages":"Pages 625-629"},"PeriodicalIF":3.7000,"publicationDate":"2024-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Process Biochemistry","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1359511324003635","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Protein fragmentation is a critical quality attribute for Fc-fusion protein production in mammalian cells. In the production of viral non-structural proteins as the form of Fc-fusion protein, fragmentation of Fc-fusion proteins occurred in two transient gene expression (TGE) systems with human embryonic kidney (HEK) 293 and Chinese hamster ovary (CHO) cells. The introduction of a flexible empirical linker reduced fragmentation in HEK293 cells, but not in CHO cells. Additionally, two rigid empirical linkers failed to restore impaired Fc-fusion proteins in CHO cells. In vitro incubation assay using conditioned culture medium and cultures supplemented with protease inhibitor cocktail suggest that fragmentation of Fc-fusion proteins in CHO cells may be due to various host cell proteins released into the culture medium. These findings suggest that the introduction of linker peptides can improve the fragmentation of Fc-fusion proteins in mammalian cells, but exhibit different fragment patterns depending on the cell type.
蛋白质破碎是哺乳动物细胞生产 Fc 融合蛋白的一个关键质量属性。在以 Fc 融合蛋白形式生产病毒非结构蛋白的过程中,Fc 融合蛋白在人胚胎肾(HEK)293 和中国仓鼠卵巢(CHO)细胞的两个瞬时基因表达(TGE)系统中发生了破碎。在 HEK293 细胞中,引入一个柔性经验连接子可减少碎裂,但在 CHO 细胞中却不能。此外,两个刚性经验连接体也无法恢复 CHO 细胞中受损的 Fc 融合蛋白。使用条件培养液和添加蛋白酶抑制剂鸡尾酒的培养液进行的体外培养试验表明,CHO 细胞中 Fc 融合蛋白的破碎可能是由于各种宿主细胞蛋白释放到培养液中造成的。这些研究结果表明,引入连接肽可改善哺乳动物细胞中 Fc 融合蛋白的破碎,但不同的细胞类型会表现出不同的破碎模式。
期刊介绍:
Process Biochemistry is an application-orientated research journal devoted to reporting advances with originality and novelty, in the science and technology of the processes involving bioactive molecules and living organisms. These processes concern the production of useful metabolites or materials, or the removal of toxic compounds using tools and methods of current biology and engineering. Its main areas of interest include novel bioprocesses and enabling technologies (such as nanobiotechnology, tissue engineering, directed evolution, metabolic engineering, systems biology, and synthetic biology) applicable in food (nutraceutical), healthcare (medical, pharmaceutical, cosmetic), energy (biofuels), environmental, and biorefinery industries and their underlying biological and engineering principles.